Abstract

In India, the pharmaceutical industry is an established industry, whereas the biotechnology industry is in the nascent phase and has been recognized as a new driver of growth. There are more than 150 biotech companies in India and established pharmaceutical companies are also diversifying into biotechnology. The report takes a look at the Pharma & Biotech Industries in India, how they have evolved, the relationship between the two industries, the innovations that have taken place in these industries, the emerging trends and the opportunities for the future and how the government is facilitating its growth. The report examines the competencies that India has developed in the Pharma & Biotech industries. It explores how these companies are endeavoring to provide better healthcare products at better prices through their expertise in pharmacology and biotechnology, and also provide high quality outsourcing services to international clients.

Learning Objectives

The case is structured to achieve the following Learning Objectives:

• Understand how the Bitech & Pharma industries are evolving in India
• Understand the relationship between the Bitech & Pharma industries
• Understand the innovations in both the industries
• Learn about the competencies developed by certain companies in both the industries
• Learn abut the growth opportunities for both the industries

Keywords

Innovation, Pharma industry, Biotech industry, Reverse Engineering, TRIPS, Genome Valley, Biotechnology Enterprise Zones, Bioinformatics, Nicholas Piramal, Value Chain, Shanta Biotech, Biocon India Ltd., Kiran Mazumdar Shaw, Ranbaxy Laboratories Ltd., Dr. Reddy's Laboratories